亚洲 · 区域市场 · Yicai Global
China’s Hengrui Pharma Soars Amid Strong Earnings Growth in First Nine Months Driven by Innovative Drug Business
Revenue from the innovative drug out-licensing business surged over 31 percent to CNY2.8 billion in the first three quarters from a year ago, mainly thanks to revenue recognized…
在 Yicai Global 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.yicaiglobal.com)
